Ascend Life Science (als) Ltd - Accounts
Ascend Life Science (als) Ltd - Accounts
Registered number | |
|
|
||
Unaudited Accounts | ||
for the period | ||
27 November 2017 to |
||
Accountant's Report
Report to the directors on the preparation of the unaudited statutory accounts of Ascend Life Science (als) Ltd for the period ended 30 November 2018.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Ascend Life Science (als) Ltd for the period ended 30 November 2018 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com
................................
Chartered Certified Accountants
Unit 2, The Pound,
Coate,
Devizes,
Wiltshire,
SN10 3LG
Balance Sheet as at |
|||
---|---|---|---|
Notes |
2018 £ |
||
Net current assets / (liabilities) |
|
||
Total assets less current liabilities |
|
||
Total net assets (liabilities) |
|
||
Capital and reserves | |||
Called up share capital | 2 |
|
|
Shareholders' funds |
|
Balance Sheet
as at
The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.
Signed on behalf of the board of directors
...............................
Mr N Hircock
Director
Approved by the board on
Company Number: 11083185 (a Private Company Limited by Shares registered in England and Wales)
Registered Office:
Unit 2 The PoundCoate
Devizes
Wiltshire
SN10 3LG
England
Notes to the Accounts
for the period 27 November 2017 to
1. | Accounting policies |
---|---|
Basis of preparation of financial statements |
2. | Share capital | |
---|---|---|
2018 | ||
£ | ||
Allotted, called up and fully paid: | ||
|
100 | |
100 |
Related party disclosures | ||
---|---|---|
Controlling party The company is controlled by Mr Nigel Hircock and Mr Ronny Bijron, by virtue of equal shareholding. |